Progress of pazopanib in clinical applications and adverse drug reaction
10.3969/j.issn.1006-0111.2016.06.005
- VernacularTitle:帕唑帕尼的临床应用和药品不良反应的研究进展
- Author:
Chenjian ZHOU
1
;
Langhuan ZHAO
;
Guoxin HU
Author Information
1. 温州市中心医院
- Keywords:
pazopanib;
clinical application;
adverse reaction
- From:
Journal of Pharmaceutical Practice
2016;34(6):497-500
- CountryChina
- Language:Chinese
-
Abstract:
Pazopanib is a multi-targeted tyrosine kinase inhibitor ,and is mainly used to treat renal cell carcinoma ,ovari-an cancer ,breast cancer ,and lung cancer .The researchers also found that pazopanib may cause diarrhea ,hypertension ,hair loss ,nausea ,and anorexia .This paper reviewed pazopanib clinical application and adverse reactions ,and provided a basis for this medication .
